Manager, Portfolio Management

Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable Biosimilar and Generic medicines. As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally. Join us—the future is ours to shape!

This position will be located at the Princeton, NJ US Headquarters site. Our Sandoz flexible hybrid working approach allows US office-based employees to work up to 50% of their monthly workday remotely. This role will not have the ability to be located remotely. Must be authorized to work in the U.S. U.S. work visa sponsorship is not available for this role now or in the future.

Responsibilities

• Portfolio Governance & Execution Readiness (Enable Timely Decisions): Prepare governance-ready materials for portfolio forums by building slides, validating data, and ensuring clear decision framing. Deliver complete, accurate materials on time with minimal rework.
• Portfolio Forecasting & Change Control Support (Maintain Integrity): Maintain portfolio forecasts and scenarios across internal and BD assets by updating our internal pipeline system. Clearly summarize changes and implications to support timely governance decisions.
• Business Development Portfolio Enablement (Support Inorganic Execution): Support BD-led assets by coordinating inputs, maintaining trackers, and reflecting deal and development changes in portfolio forecasts and materials as opportunities progress.
• Process, Tools & AI Enablement (Deliver Step-Change Efficiency): Build and improve templates, dashboards, automation, and AI-enabled workflows on product evaluations that reduce manual effort, rework, and cycle time. Convert repetitive work into scalable, low-touch processes.
• Operating Rhythm Management (Keep the Portfolio Running): Manage portfolio timelines, data refreshes, and deliverables across the internal pipeline, BD funnel, and governance activities to ensure readiness ahead of decision points.
• Cross-Functional Coordination (Get Work Done in a Matrix): Coordinate inputs across R&D, Regulatory, Commercial, Finance, Supply, and BD teams. Resolve data gaps or inconsistencies early to prevent downstream delays.
• Execution Accountability & Follow-Through (Close the Loop): Track decisions, actions, owners, and timelines from portfolio forums and ensure updates are reflected consistently in materials, forecasts, and next steps.
• Special Projects & Priority Analyses (Deliver on Demand): Execute priority analyses or execution-focused portfolio initiatives as assigned, delivering clear, practical outputs with minimal oversight.
• Risk Identification and Escalation (Protect Decision Quality): Proactively surface timeline, data integrity, or cross-functional execution risks that could compromise portfolio readiness or decision quality.

Key Performance Indicators

• Governance Readiness & Quality: Delivers complete, accurate, decision-ready materials for portfolio governance forums, with clear framing, validated data, and zero rework.
• Forecast Integrity & Responsiveness: Maintains high-confidence, up-to-date portfolio forecasts that respond rapidly to new information, scenario changes, and leadership requests.
• Execution Predictability: Ensures portfolio deliverables, analyses, and timelines are reliably met, reducing surprises and execution variability.
• Process & Tool Impact: Improves portfolio execution outcomes through standardized processes, fit-for-purpose tools, and measurable productivity gains.
• AI-Driven Efficiency Gains: Replaces manual, repetitive work with AI-enabled workflows to materially reduce cycle time and analyst effort.
• Leadership Support: Extends Director and Executive Director effectiveness by ensuring execution readiness, proactive issue surfacing, and seamless follow-through on decisions.

Requirements

• Execution-First Orientation: Relentlessly focused on execution excellence—turning direction into accurate, on-time outputs, not owning portfolio strategy or final investment decisions.
• Project & Portfolio Discipline: Manages multiple priorities with rigor, structure, and strong follow-through across complex, cross-functional portfolios.
• Data, Analytics & AI Fluency (Copilot, Salesforce.com, Power BI): Uses data, dashboards, and AI tools to drive insights, automate workflows, and improve decision speed and quality.
• Executive-Ready Communication: Produces clear, concise, and decision-oriented materials suitable for senior leadership without rework or translation.
• Cross-Functional Collaboration: Works seamlessly across R&D, BD, Regulatory, Supply Chain, Finance, and Commercial to ensure aligned and timely portfolio execution.

Qualifications

• Education: Bachelor’s degree in Pharmacy, Life Sciences, Business, Engineering, or Finance is required.
• Experience: 3+ years in pharma/biotech with exposure to generics; portfolio or execution roles preferred.
• Travel Requirements: Up to 5% travel.
• Ability to work independently from home or office when necessary for business purposes.

Benefits

Sandoz offers a generous employee benefits package that includes:

• Competitive salary
• Health insurance coverage for medical, prescription drugs, dental, and vision
• Generous company match for retirement savings accounts
• Generous paid time off
• Hybrid work policy combining in-person and remote work for flexibility

Pay

The pay range for this position at commencement of employment is expected to be between $118,500 - $220,100 per year. Final pay determinations will depend on various factors, including geographical location, experience level, knowledge, skills, and abilities. The total compensation package may also include other elements such as a sign-on bonus, restricted stock units, and discretionary awards.

About Sandoz

Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, provided more than 900 million patient treatments across 100+ countries in 2024. With investments in new development capabilities, production sites, acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost, high-quality medicines sustainably. Our momentum is powered by an open, collaborative culture driven by talented and ambitious colleagues, where diversity is welcomed and personal growth is supported.